Immunotherapy: PD-1 Antibodies and Beyond- Dr. Carvajal Melanoma Education Symposium 2014
5 Visualizações
• 07/30/23
0
0
Embutir
administrator
Assinantes
Dr. Carvajal, Director of Developmental Therapeutics and Assistant Attending Physician at Memorial Sloan Kettering Cancer Center describes the future of immunotherapy and clinical trials for metastatic melanoma.
Agency: BoldSpark
Director: Sean Willis
BoldSparkCollective.com
Mostre mais
Comentários do Facebook
SORT BY-
Melhores Comentários
-
Últimos Comentários